Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.145 +0.185 (+6.25%)
Streaming Delayed Price Updated: 2:08 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Agenus Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Earnings Preview For Agenus ↗
 
Via Benzinga
News headline image
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 ↗
 
Via Benzinga
Looking Into Agenus's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Why Shares of Agenus Rose 12.5% on Friday ↗
Agenus presented data this week on a combination therapy. 
Via The Motley Fool
News headline image
Agenus (AGEN) Q3 2022 Earnings Call Transcript ↗
AGEN earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
7 Hot Stocks to Book Profits In Before 2023 ↗
With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in. 
Via InvestorPlace
News headline image
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
News headline image
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy ↗
 
Via Benzinga
News headline image
Why Agenus Stock Rose 18.4% on Thursday ↗
The company's shares climbed with help from insider buying. 
Via The Motley Fool
News headline image
Miniso Group, Monday.com And Other Big Gainers From Monday ↗
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
Via Benzinga
News headline image
Short Volatility Alert: Agenus Inc. ↗
On Tuesday, shares of Agenus Inc. (NASDAQ: AGEN) experienced volatile short activity. After the activity, the stock price went down 0.00% to $2.66. The overall sentiment for AGEN has been Neutral. 
Via Benzinga
News headline image
Recap: Agenus Q2 Earnings ↗
  Agenus (NASDAQ:AGEN) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
10 Best Medical Stocks Under $5 ↗
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the... 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million. 
Via Benzinga
News headline image
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday ↗
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
News headline image
7 Penny Stocks That Actually Have a Buy Rating ↗
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now. 
Via InvestorPlace
News headline image
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
News headline image
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate ↗
Agenus (NASDAQ: AGEN) has initiated Phase 2 ACTIVATE trials of botensilimab to advance globally in metastatic patients who have progressed on available therapies. This global Phase 2 program include... 
Via Benzinga
News headline image
Agenus Earnings Perspective: Return On Capital Employed ↗
According to Benzinga Pro data, during Q2, Agenus (NASDAQ:AGEN) posted sales of $20.93 million. Earnings were up 2.71%, but Agenus still reported an overall loss of $49.23 million. 
Via Benzinga
News headline image
Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Agenus Commences Initial-Stage Advanced Tumors Study ↗
Agenus (NASDAQ: AGEN) has dosed the first patient in the Phase 1 clinical study of AGEN1571 in advanced solid tumors. AGEN1571is a novel anti-ILT2 antibody designed to modulate tumor-associated... 
Via Benzinga
News headline image
U.S. Stocks Turn Negative; 2U Shares Spike Higher ↗
U.S. stocks pared gains midway through trading, with all the three major indices turning lower on Wednesday. 
Via Benzinga
News headline image
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday ↗
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. 
Via Benzinga
News headline image
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.